» Articles » PMID: 19939412

Impact of Positive Pleural Lavage Cytology on Survival in Patients Having Lung Resection for Non-small-cell Lung Cancer: An International Individual Patient Data Meta-analysis

Abstract

Objectives: Pleural lavage cytology is the microscopic study of cells obtained from saline instilled into and retrieved from the chest during surgery for non-small-cell lung cancer. The aims of this study were to collate multi-institutional individual patient data for meta-analysis to determine independence as a prognostic marker and to characterize the impact of positive results on stage-adjusted survival.

Methods: We identified 31 publications from 22 centers/research groups that performed pleural lavage cytology during surgery for non-small-cell lung cancer and invited submission of individual patient data. Actuarial survival was calculated using Kaplan-Meier methods, and comparisons were performed using the log-rank test. Cox proportional hazards regression was used to ascertain the covariates associated with survival.

Results: By January 1, 2008, submissions were received internationally from 11 centers with individual data from 8763 patients. In total, 511 (5.8%) patients had a positive pleural lavage cytology result, and this was shown to be an independent predictor of adverse survival associated with a hazard ratio of 1.465 (1.290-1.665; P < .001) compared with a reference hazard ratio of 1 for a negative result. On statistical modeling, the best adjustment for patients with a positive pleural lavage cytology result was a single increase in the T category assigned to the case, up to a maximum of T4. Correction for differences in survival were obtained in stages IB (P = .315) and IIB (P = .453), with a degree of correction in stage IIIA (P = .07).

Conclusions: Pleural lavage cytology should be considered in all patients with non-small-cell lung cancer suitable for resection. A positive result is an independent predictor of adverse survival, and the impact on survival suggests that it may be appropriate to upstage patients by 1 T category.

Citing Articles

Enhancing Cancer Treatment Through Combined Approaches: Photodynamic Therapy in Concert with Other Modalities.

Hong G, Chang J Pharmaceutics. 2024; 16(11).

PMID: 39598543 PMC: 11597730. DOI: 10.3390/pharmaceutics16111420.


Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study.

Ferguson J, Tsim S, Kelly C, Alexander L, Shad S, Neilly M BMJ Open Respir Res. 2023; 10(1).

PMID: 37996118 PMC: 10668291. DOI: 10.1136/bmjresp-2023-001771.


Intraoperative rapid diagnosis of pleural lavage cytology in non-small cell lung cancer.

Mizuno K, Isaka M, Terada Y, Konno H, Mizuno T, Tone K Gen Thorac Cardiovasc Surg. 2023; 72(2):127-133.

PMID: 37395938 DOI: 10.1007/s11748-023-01954-3.


Overall 5-year survival rate and disease-free survival after segmentectomy versus lobectomy in patients with non-small cell lung cancer.

Kadeetham K, Ngodngamthaweesuk M, Kantathut N, Samankatiwat P, Cherntanomwong P, Leelayana P SAGE Open Med. 2022; 10:20503121221142171.

PMID: 36568340 PMC: 9768823. DOI: 10.1177/20503121221142171.


The Evolving Concept of Complete Resection in Lung Cancer Surgery.

Rami-Porta R Cancers (Basel). 2021; 13(11).

PMID: 34070418 PMC: 8197519. DOI: 10.3390/cancers13112583.